Goldman Sachs
TELA icon

Goldman Sachs’s TELA Bio TELA Stock Holding History

Goldman Sachs’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.79K Buy
+10,383
New +$8.49K ﹤0.01% 6486
2024
Q3 		– Sell
-153,749
Closed -$723K – 6065
2024
Q2 		$723K Buy
153,749
+141,140
+1,119% +$744K ﹤0.01% 4617
2024
Q1 		$71.5K Buy
+12,609
New +$83.2K ﹤0.01% 5289
2023
Q2 		– Sell
-35,155
Closed -$374K – 6062
2023
Q1 		$374K Buy
+35,155
New +$388K ﹤0.01% 4994
2022
Q1 		– Sell
-19,662
Closed -$252K – 6904
2021
Q4 		$252K Sell
19,662
-3,558
-15% -$45.1K ﹤0.01% 5767
2021
Q3 		$317K Sell
23,220
-903
-4% -$12.6K ﹤0.01% 5465
2021
Q2 		$389K Buy
24,123
+3,605
+18% +$49.4K ﹤0.01% 5361
2021
Q1 		$306K Buy
20,518
+176
+0.9% +$2.65K ﹤0.01% 5422
2020
Q4 		$306K Sell
20,342
-10,344
-34% -$168K ﹤0.01% 4877
2020
Q3 		$508K Buy
+30,686
New +$431K ﹤0.01% 4473

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $448M AUM 50.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's TELA Position: Q2 2026 in Review

Goldman Sachs opened a new position in TELA Bio (TELA) in Q2 2026: 10,383 shares worth $7.79K. The stake represents ﹤0.01% of the portfolio and ranks #6486 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in TELA as recently as Q2 2024.

Goldman Sachs first reported a position in TELA in Q3 2020 and has held it in 10 quarters since. The position peaked at $723K in Q2 2024. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Goldman Sachs held 10,383 shares of TELA Bio worth $7.79K as of Q2 2026.
  • TELA Bio was a new Goldman Sachs position in Q2 2026.
  • TELA Bio made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6486 holding.
  • Goldman Sachs first reported a position in TELA Bio in Q3 2020 and has held it in 10 quarters since.
  • Goldman Sachs's TELA Bio position peaked at $723K in Q2 2024.
  • 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.